Concepedia

Pier Paolo Fattori

PP

Statistics

Publications

19

Citations

2.1K

H-Index

15

Active since

1994

Affiliations

University of Bologna(Current)

Ospedale Infermi di Rimini

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Istituti di Ricovero e Cura a Carattere Scientifico

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Pier Paolo Fattori is an author at University of Bologna specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1994–2020

19

Publications

19

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince, Youn H. Kim, Reinhard Dummer et al. · The Lancet · 2017 · 569 citations

, , +9

Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses.

Ilaria Panzini, Lorenzo Gianni, Pier Paolo Fattori et al. · PubMed · 2002 · 198 citations

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial

Umberto Vitolo, Annalisa Chiappella, Silvia Franceschetti et al. · The Lancet Oncology · 2014 · 182 citations

, , +9

Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.

Pier Luigi Zinzani, Maurizio Martelli, M Bertini et al. · PubMed · 2002 · 181 citations

Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma.

Pier Luigi Zinzani, Enzo Pavone, Sergio Storti et al. · PubMed · 1997 · 163 citations

Rows per page

1–5 of 19